Chapter review

Fitzgerald PMHNP board review. ch15. Disorders of Children and Adolescents. This is drive 1 of 4. When I say Pause. Answer. wait, then I will give the answer. New section. ADHD Diagnostic Architecture and FIDGETY Mnemonic. Topic. ADHD Subtype Clusters — Part 1: Inattention. Bottom Line Summary. * Diagnostic criteria require at least 6 inattention symptoms for children up to age 16, or at least 5 symptoms for individuals age 17 and older, persisting for at least 6 months. * Several inattentive or hyperactive-impulsive symptoms must be present prior to 12 years of age. * Clear impairment from symptoms must be present across at least 2 distinct settings, such as at home and in the classroom. * Elementary school prevalence is 7% to 8% in children and 2.5% in adults, with a male-to-female ratio of 2 to 1 in children and 1.6 to 1 in adults. * Heritability for ADHD is approximately 75%, carrying a 2-to-8-fold increased risk among siblings of affected children. * First-line treatment for school-age children combines stimulant pharmacotherapy using methylphenidate or amphetamine preparations with behavioral interventions. * Non-stimulant alternatives include atomoxetine (Strattera) or alpha-2 adrenergic agonists like guanfacine and clonidine, which are indicated when stimulants are contraindicated or induce motor tics. * Up to 70% of individuals with ADHD meet criteria for a comorbid psychiatric condition, with anxiety disorders and learning disabilities being the most common. Clinical Framework and Key Signposts. * First-line: Stimulants, including methylphenidate preparations and amphetamine salts, represent first-line pharmacotherapy for ADHD in school-age children, adolescents, and adults. They should be combined with behavioral strategies and parent support resources such as CHADD. * Safety alert: Stimulants increase presynaptic dopamine and norepinephrine, requiring baseline and quarterly monitoring of height, weight, blood pressure, and pulse. Avoid or use with extreme caution in structural cardiac abnormalities, uncontrolled hypertension, active substance use disorders, severe agitation, or active motor tics. * Board trap: Do not assume a child with a well-controlled seizure disorder cannot receive stimulants. Stimulants remain safe and effective when seizures are stabilized on an anticonvulsant. Avoid bupropion in patients with epilepsy because bupropion significantly lowers the seizure threshold. ADHD Subtype Clusters: Inattention Domain and Diagnostic Architecture. Attention-Deficit/Hyperactivity Disorder is classified into three distinct diagnostic subtypes: Predominantly Inattentive, Predominantly Hyperactive/Impulsive, and Combined. Evaluating the inattention subtype requires assessing nine specific behavioral domains against strict age and setting thresholds. For children up to 16 years of age, at least 6 of the 9 inattention symptoms must be present often for at least 6 months. For adolescents aged 17 and older and adults, the diagnostic threshold drops to 5 or more symptoms. Several symptoms must have been present prior to age 12, and impairment must be documented across at least two settings, such as home and school, causing demonstrable social, academic, or occupational dysfunction. The nine clinical domains of inattention encompass: 1. Failing to give close attention to details or making careless mistakes in schoolwork, work, or other activities. 2. Difficulty sustaining attention in tasks, lengthy lectures, or play activities. 3. Appearing not to listen when spoken to directly, as if the mind is elsewhere without any obvious distraction. 4. Failing to follow through on instructions and failing to finish schoolwork, chores, or workplace duties due to starting tasks but quickly losing focus. 5. Difficulty organizing tasks and activities, manifested by messy backpacks, disorganized lockers, poor time management, and failing to turn in completed homework assignments. 6. Avoiding, disliking, or being reluctant to engage in tasks that require sustained mental effort, such as school projects or lengthy reports. 7. Frequently losing necessary items required for tasks or activities, such as school materials, pencils, books, wallets, or keys. 8. Being easily distracted by extraneous environmental stimuli or unrelated thoughts. 9. Forgetfulness in daily activities, routine chores, or running errands. Diagnostic evaluation relies on gathering multimodal data. Standardized tools like the Vanderbilt Assessment Scale feature parent and teacher versions that evaluate inattention, hyperactivity, disruptive behaviors, anxiety, depression, and academic performance. Broad tools like the Pediatric Symptom Checklist (PSC-17 or PSC-35) are often sent to families prior to initial specialty visits to screen broad emotional and behavioral domains. When academic achievement lags behind cognitive potential, formal neuropsychological testing using the Wechsler Intelligence Scale for Children (WISC) should be ordered to rule out comorbid learning disabilities. In terms of clinical course, 60% to 85% of pediatric cases persist into adolescence, and 60% persist into adulthood. While overt motor hyperactivity tends to decline with age, inattention and impulsivity persist into adulthood. Remission typically occurs between ages 12 and 20. Persistent untreated symptoms elevate the risk for academic failure, job instability, substance use disorders, conduct problems, and social impairment. Sample Test Questions. Question 1. Cara, a 12-year-old 7th grader, is diagnosed with juvenile myoclonic epilepsy (JME) and her seizures are well controlled on topiramate. Before her JME diagnosis, Cara had been diagnosed with ADHD and treated with methylphenidate, which was discontinued when a seizure disorder was diagnosed. Now Cara is failing in school, and the Vanderbilt form from her teacher demonstrates significant inattention and distraction. Cara and her mother request medication for ADHD. Which of the following is the best option for Cara? A. Treat with bupropion and follow up in 1 to 2 weeks B. Start methylphenidate and follow up in 1 to 2 weeks C. Refer to a psychotherapist for organizational counseling D. Consult a neuropsychologist for ADHD testing to confirm the diagnosis Pause. Answer: B. Why it is correct: Methylphenidate is a first-line stimulant that remains the gold standard for treating ADHD. It can be safely used when a co-occurring seizure disorder is well-controlled on an anticonvulsant regimen. Why the other choices are wrong: * A is wrong because bupropion significantly lowers the seizure threshold and is strictly contraindicated in patients with epilepsy. * C is wrong because organizational counseling alone is insufficient when severe inattention causes academic failure that warrants first-line pharmacotherapy. * D is wrong because her ADHD diagnosis was previously established, making repeat neuropsychological testing an unnecessary delay in treatment. Question 2. When considering management of ADHD in a 15-year-old, the use of a stimulant medication should be avoided or used with caution in the presence of which of the following? (Choose all that apply) A. Hypertension B. Cardiac abnormality C. Type 2 diabetes D. Prior history of substance use disorder E. Presence of motor tics F. History of anxiety or agitated states Pause. Answer: A, B, D, E, and F. Why it is correct: Stimulants produce sympathomimetic and dopaminergic effects, requiring caution or avoidance in patients with hypertension, structural cardiac abnormalities, personal or family history of substance abuse, active motor tics, or severe anxiety and agitation. Why the other choice is wrong: * C is incorrect because Type 2 diabetes is not a contraindication or caution for stimulant therapy, as stimulants do not adversely affect glucose metabolism. Question 3. An 8-year-old boy recently diagnosed with ADHD is prescribed a methylphenidate stimulant (Ritalin SR) as initial treatment. At the follow-up visit 2 weeks later, the mother reports some improvement in ADHD symptoms, but she has noticed the development of a tic consisting of eye blinking and neck jerking. The NP recommends: A. Increasing the dose of methylphenidate by switching to methylphenidate extended-release (Concerta) B. Switching to dextroamphetamine C. Switching to atomoxetine (Strattera) D. Adding bupropion to his regimen Pause. Answer: C. Why it is correct: The emergence of new motor tics during stimulant therapy warrants discontinuing the stimulant and switching to a non-stimulant agent such as atomoxetine (Strattera). Why the other choices are wrong: * A is wrong because increasing the methylphenidate dose or switching to Concerta worsens tic severity. * B is wrong because switching to another stimulant like dextroamphetamine continues dopaminergic stimulation and maintains tic exacerbation. * D is wrong because adding bupropion fails to remove the offending stimulant and does not address stimulant-induced tics. Question 4. When initiating methylphenidate therapy for a 9-year-old boy with ADHD, the PMHNP educates the family on the possibility of all of the following potential adverse effects EXCEPT: A. Headache B. Hypersomnia C. Loss of appetite or weight loss D. Exacerbation of tic disorder Pause. Answer: B. Why it is correct: Stimulant medications cause central arousal leading to insomnia and sleep disruption rather than hypersomnia. Why the other choices are wrong: * A is wrong because transient headaches are a known potential adverse effect during stimulant initiation. * C is wrong because appetite suppression and subsequent weight loss are common central side effects of stimulants. * D is wrong because dopaminergic enhancement from stimulants can unmask or exacerbate underlying tic disorders. 💡 Want to test your recall on the hyperactive/impulsive subtype next, or move directly to pediatric psychopharmacology dosing and monitoring rules? Next. Topic. ADHD Subtype Clusters — Part 2: Hyperactivity and Impulsivity. Fitzgerald Chapter 15: ADHD Subtype Clusters: Hyperactivity and Impulsivity. Bottom Line. - **ADHD hyperactive-impulsive subtype** requires 6 or more out of 9 criteria for children under 17 years, and 5 or more out of 9 criteria for individuals 17 years or older. - Symptoms must persist for at least 6 months, have an onset prior to age 12, and cause demonstrable impairment across at least 2 distinct settings. - Elementary school prevalence is 7 to 8 percent in children and 2.5 percent in adults, with a 2 to 1 male-to-female ratio in youth and a high heritability rate of 75 percent. - **First-line** pharmacotherapy for school-aged youth is stimulant medication (**methylphenidate** or **amphetamine** salts), whereas behavioral therapy is **first-line** for children under 5 years. - **Safety alert**: Baseline cardiac risk evaluation, blood pressure, pulse, height, and weight must be monitored at initiation and quarterly during stimulant treatment. - **Board trap**: **Bupropion** is strictly contraindicated in patients with seizure disorders due to lowering the seizure threshold, whereas **methylphenidate** can be safely restarted if seizures are well controlled on anticonvulsants. - If new motor tics develop during stimulant therapy, discontinue the stimulant and switch to **atomoxetine** (**Strattera**). ADHD Diagnostic Architecture and FIDGETY Mnemonic. Diagnostic Architecture. - Core threshold: 6 or more symptoms of hyperactivity-impulsivity for individuals up to 16 years of age. 5 or more symptoms required for individuals 17 years of age and older. - Duration requirement: Symptoms must persist for at least 6 consecutive months to a degree that is maladaptive and inconsistent with developmental level. - Age of onset gate: Several hyperactive-impulsive or inattentive symptoms must be present prior to age 12 years. - Setting gate: Symptoms or impairment must be present in 2 or more settings, such as home, school, sports, or work. - Functional interference: Clear evidence of significant interference with social, academic, or occupational functioning. FIDGETY Mnemonic. Use this 7-letter mnemonic to recall the 9 core hyperactivity-impulsivity symptoms: - **F**: Fidgets with hands or feet, or squirms in seat. - **I**: In seat fails to remain when remaining seated is expected in classroom or work settings. - **D**: Driven by a motor, acting as if on the go, or running/climbing excessively in inappropriate situations. - **G**: Gabs excessively, demonstrating continuous over-talkativeness. - **E**: Early answer blurted out before a question has been fully completed. - **T**: Turns waiting difficulty, struggling to wait turn in lines or group games. - **Y**: Yells out, interrupts, or intrudes on others by intruding into conversations or games. Developmental Evolution. - Young children manifest hyperactivity as overt gross motor behaviors like climbing on furniture, running constantly, and failing to engage in quiet play. - Adolescents and adults display less gross motor running but experience a subjective internal feeling of restlessness, excessive talking, and impulsive decision-making. Clinical Signposts and Exam Pearls. First-line. - **First-line** treatment for children aged 6 and older with ADHD is stimulant pharmacotherapy (**methylphenidate** or **dextroamphetamine**). - **First-line** intervention for preschool children under age 5 is evidence-based parent training in behavior management before initiating medications. - **First-line** strategy when motor tics develop during stimulant therapy is switching to a non-stimulant like **atomoxetine**. Board trap. - Do not confuse ADHD hyperactivity with bipolar mania. Mania is episodic and cyclic, whereas ADHD is a chronic baseline state. Both share distractibility and excessive talking, but grandiosity and decreased need for sleep point to mania. - Do not withhold stimulants in patients with well-controlled seizure disorders. **Methylphenidate** does not lower seizure threshold when seizures are stabilized on anticonvulsants, whereas **bupropion** is strictly contraindicated. - Expected stimulant side effects include insomnia, reduced appetite, weight loss, and transient headache. Hypersomnia is not a stimulant side effect. Safety alert. - Monitor blood pressure, heart rate, height, and weight at baseline and quarterly during stimulant therapy to evaluate for cardiovascular changes and growth suppression. - Exercise caution when prescribing stimulants in patients with hypertension, structural cardiac abnormalities, active motor tics, severe anxiety/agitation, or a prior history of substance use disorder. Compare and Distinguish. Hyperactivity in ADHD vs Bipolar I Mania - Think: ADHD is chronic and continuous from childhood; mania is episodic with distinct mood changes. - Priority: Distinguish baseline restlessness from acute manic grandiosity and decreased need for sleep. - Boards are testing: ADHD symptoms do not wax and wane in discrete manic cycles. ADHD Hyperactive Subtype vs Anxiety Disorders - Think: Anxiety-driven motor restlessness is linked to internal worry; ADHD motor restlessness is driven by executive dysfunction. - Priority: Assess whether restlessness occurs only during anxious triggers or across all daily settings continuously. - Boards are testing: Anxiety and ADHD co-occur in up to 70 percent of cases, but primary anxiety features excessive apprehension. ADHD Impulsivity vs Oppositional Defiant Disorder - Think: ADHD impulsivity is unintended impatience or blurted responses; Oppositional Defiant Disorder is deliberate defiance, spitefulness, and arguing with authority. - Priority: Oppositional Defiant Disorder is treated with family behavioral therapy; ADHD is treated with stimulants. - Boards are testing: Academic failure is not a diagnostic criterion for Oppositional Defiant Disorder or conduct disorder. Sample Test Questions. Question 1. When considering management of ADHD in a 15-year-old, the use of a stimulant medication should be avoided or used with caution in the presence of which of the following? Select all that apply. A. Hypertension B. Cardiac abnormality C. Type 2 diabetes D. Prior history of substance use disorder E. Presence of motor tics F. History of anxiety or agitated states Pause. Answer: A, B, D, E, F. Why It Is Correct: Stimulants cause sympathomimetic effects including increased heart rate and blood pressure, require caution in cardiac disease, can worsen motor tics or anxiety, and carry abuse potential in active or prior substance use disorders. Type 2 diabetes is not a contraindication or caution for stimulant use. Why the Other Choices Are Wrong: - Option C: Type 2 diabetes does not require special caution or avoidance when prescribing stimulant medications. Test-Taking Pearl: Always identify physical and cardiovascular contraindications before prescribing sympathomimetic stimulants. Question 2. An 8-year-old boy recently diagnosed with ADHD is prescribed a methylphenidate stimulant, Ritalin SR, as an initial treatment. At the follow-up visit 2 weeks later, the mother reports some improvement in ADHD symptoms, but she has noticed the development of a tic consisting of eye blinking and neck jerking. The NP recommends: A. Increasing the dose of methylphenidate. B. Switching to methylphenidate extended-release (Concerta). C. Switching to atomoxetine (Strattera). D. Adding bupropion to his regimen. Pause. Answer: C. Why It Is Correct: When new motor tics emerge during stimulant therapy, the best action is to discontinue the stimulant and switch to a non-stimulant medication such as **atomoxetine** (**Strattera**). Why the Other Choices Are Wrong: - Option A: Increasing the dose of **methylphenidate** would exacerbate the motor tics. - Option B: Switching to another formulation of **methylphenidate** maintains stimulant exposure and will not resolve the tics. - Option D: Adding **bupropion** is unnecessary, adds polypharmacy, and does not address stimulant-induced tics. Test-Taking Pearl: New onset of motor tics on a stimulant requires switching to a non-stimulant agent like **atomoxetine** or an alpha-2 agonist. Question 3. When initiating methylphenidate therapy for a 9-year-old boy with ADHD, the PMHNP educates the family on the possibility of all of the following potential adverse effects except: A. Headache B. Hypersomnia C. Loss of appetite or weight loss D. Exacerbation of tic disorder Pause. Answer: B. Why It Is Correct: Stimulants are central nervous system activators that cause insomnia rather than hypersomnia. Why the Other Choices Are Wrong: - Option A: Transient headache is a known potential adverse effect during initial stimulant titration. - Option C: Appetite suppression and weight loss are common adverse effects of **methylphenidate**. - Option D: Stimulants can unmask or exacerbate underlying tic disorders. Test-Taking Pearl: Expect central nervous system stimulation side effects such as insomnia and appetite loss when initiating **methylphenidate**, not sedation or hypersomnia. Question 4. Cara, a 12-year-old 7th grader, is diagnosed with juvenile myoclonic epilepsy, and her seizures are well controlled on topiramate. Before her epilepsy diagnosis, Cara had been diagnosed with ADHD and treated with methylphenidate, which was discontinued when seizures began. Now Cara is failing in school, and the Vanderbilt form from her teacher demonstrates significant inattention and distraction. Cara and her mother request medication for ADHD. Which of the following is the best option for Cara? A. Treat with bupropion and follow up in 1 to 2 weeks. B. Start methylphenidate and follow up in 1 to 2 weeks. C. Refer to a psychotherapist for organizational counseling. D. Consult a neuropsychologist for ADHD testing to confirm the diagnosis. Pause. Answer: B. Why It Is Correct: **Methylphenidate** is the gold-standard treatment for ADHD. Because her seizure disorder is well controlled on **topiramate**, restarting **methylphenidate** with close monitoring in 1 to 2 weeks is safe and effective. Why the Other Choices Are Wrong: - Option A: **Bupropion** lowers the seizure threshold and is strictly contraindicated in patients with a seizure history. - Option C: Psychotherapy alone is insufficient for severe core ADHD inattention when gold-standard pharmacotherapy is indicated. - Option D: ADHD was already diagnosed and confirmed previously, making re-testing unnecessary and delaying care. Test-Taking Pearl: Controlled epilepsy is not an absolute contraindication to stimulants, but **bupropion** is strictly contraindicated in any patient with a seizure history. Next Study Step. Review **Fitzgerald Chapter 15** Part 3 on Disruptive, Impulse-Control, and Conduct Disorders to master the differential distinctions between **Oppositional Defiant Disorder**, **Conduct Disorder**, and **ADHD**. 💡 Want to test your recall on stimulant vs non-stimulant pharmacotherapy, or dive into pediatric mood and anxiety presentation rules next? Next. New section. Autism Spectrum Disorder (ASD) Core Domains. Topic. Pharmacological Management of ASD Symptoms. FITZGERALD CH15 — Disorders of Children and Adolescents. Branch: ADHD, ASD, and Disruptive Behavior: Criteria, Age Gates, and First-Line. Section: Autism Spectrum Disorder (ASD) Core Domains. Leaf: Pharmacological Management of ASD Symptoms. Bottom Line. - **Autism Spectrum Disorder** requires persistent deficits across two core domains: social communication/interaction and restricted, repetitive patterns of behavior or interests. - Pharmacotherapy does not cure or treat core social communication deficits in **Autism Spectrum Disorder**. - **Risperidone** and **aripiprazole** are the only two atypical antipsychotics with FDA approval for treating irritability, aggression, and explosive tantrums associated with **Autism Spectrum Disorder** in pediatric patients. - **Applied Behavioral Analysis** (ABA) therapy is the gold-standard, **first-line** non-pharmacological behavioral intervention, recommended for up to 20 hours per week starting early in development. - The M-CHAT-R (Modified Checklist for Autism in Toddlers, Revised) is the standard screening tool used between 16 and 30 months; a score of 8 or higher indicates high risk for **Autism Spectrum Disorder**. - Initial clinical presentations often involve parents suspecting a hearing impairment due to the child's lack of response to their name or poor social responsiveness. - Prescribing guidelines require starting at low doses, titrating slowly, avoiding polypharmacy, and monitoring baseline weight, blood pressure, fasting lipids, and fasting glucose quarterly. Must-Know Concepts for Boards. **First-line**. - **Applied Behavioral Analysis** (ABA) therapy is the primary **first-line** non-pharmacological treatment of choice for managing behavior in **Autism Spectrum Disorder**. - **Risperidone** and **aripiprazole** are **first-line** FDA-approved psychotropic choices when severe irritability, physical aggression, temper tantrums, or self-injurious behaviors impair functioning or safety. **Safety alert**. - Baseline metabolic screening is mandatory before starting **risperidone** or **aripiprazole**. Measure weight, height, body mass index, blood pressure, fasting blood glucose, and fasting lipid panel at baseline and monitor quarterly due to high risks of rapid weight gain, metabolic syndrome, hyperprolactinemia, and extrapyramidal symptoms. **Board trap**. - Do not prescribe psychotropic medications with the expectation of correcting core social deficits, speech delays, or lack of eye contact. Medications target secondary behavioral symptoms like severe irritability, severe hyperactivity, or aggression. - When parents report a toddler fails to respond to spoken commands or verbal cues, do not assume a primary hearing deficit without first screening for **Autism Spectrum Disorder** using the M-CHAT-R tool. Spoken Study Overview: Pharmacological and Behavioral Management of ASD. Core Diagnostic Domains. **Autism Spectrum Disorder** is characterized by persistent impairment in social communication and social interaction across multiple contexts, alongside restricted and repetitive patterns of behavior, interests, or activities. Symptoms must be present in the early developmental period and cause clinically significant functional impairment. Screening and Early Identification. The M-CHAT-R screening tool evaluates toddlers between 16 and 30 months of age. A score between 0 and 2 indicates low risk, 3 to 7 indicates medium risk requiring follow-up, and 8 to 20 indicates high risk requiring immediate diagnostic evaluation and specialist referral. Parents frequently present with concerns that the child has a hearing problem because the child does not acknowledge parental calls, avoids eye contact, or displays social unresponsiveness. Pharmacological Management Principles. Psychotropic medications are adjunctive interventions. Target specific secondary symptoms rather than the overarching neurodevelopmental diagnosis. - For severe irritability, physical aggression, explosive temper tantrums, and self-injurious behavior: Initiate **risperidone** or **aripiprazole**. Start at the lowest effective dose and titrate gradually. - For co-occurring inattention or hyperactivity: Evaluate for comorbid ADHD. Stimulants like **methylphenidate** or non-stimulants like **atomoxetine** and alpha-2 adrenergics like **guanfacine** may be used, though children with ASD display higher sensitivity to side effects. - Practice cautious prescribing: Avoid polypharmacy and re-evaluate the ongoing need for medication periodically. Non-Pharmacological Behavioral Therapy. **Applied Behavioral Analysis** (ABA) therapy utilizes structured behavioral reinforcement principles to build functional communication, improve social skills, and replace destructive behaviors with adaptive responses. High-intensity ABA therapy, ideally 20 hours per week initiated around age 4, yields the greatest long-term functional improvement. Fitzgerald Sample Exam Questions. Question 20. A mother brings in her 2-year-old daughter for an evaluation at the suggestion of the pediatrician. The referral from the pediatrician reports that the child scored an 8 on the M-CHAT-R screening tool. Upon examination, the PMHNP could anticipate finding all of the following except: - A. Difficulty understanding nonverbal communication - B. Abnormal fixation on specific activities - C. Frequent references to an imaginary friend - D. Parents are concerned that there is a hearing problem Pause. Answer: C Why It Is Correct. Frequent references to an imaginary friend is a normal developmental milestone for preschool children (typically between ages 2.5 and 4 years) and is not a feature of **Autism Spectrum Disorder**. An M-CHAT-R score of 8 indicates high risk for ASD, where imaginative and symbolic play is typically absent or delayed. Why the Other Choices Are Wrong. - A: Incorrect because difficulty understanding nonverbal communication is a core diagnostic deficit in social communication for **Autism Spectrum Disorder**. - B: Incorrect because abnormal fixation on specific activities or restricted, repetitive interests is a cardinal criterion of **Autism Spectrum Disorder**. - D: Incorrect because parents of toddlers with ASD frequently suspect a primary hearing impairment due to the child's lack of response to their name and social unresponsiveness. Question 21. JT is a 10-year-old male who was diagnosed with level 2 **Autism Spectrum Disorder** (ASD) 3 years ago by a specialty center. His family recently moved to a new town and must reestablish care and services. JT is having difficulty in his new school. Mom gets calls almost daily about his temper tantrums, and that he occasionally is poking his peers with pencils and other school tools. The PMHNP recognizes that priorities of care include: - A. Applied behavioral analysis therapy and risperidone - B. Homeschooling with restricted use of pencils and other tools - C. An evaluation for concomitant attention deficit disorder - D. Strict enforcement of discipline and adherence to school rules Pause. Answer: A Why It Is Correct. **Applied Behavioral Analysis** (ABA) therapy is the gold-standard evidence-based behavioral intervention for **Autism Spectrum Disorder**, and **risperidone** is an FDA-approved atypical antipsychotic specifically indicated for managing severe irritability, temper tantrums, and aggression in pediatric patients with ASD. Why the Other Choices Are Wrong. - B: Incorrect because removing the child from school isolates him and restricts social development rather than delivering evidence-based behavioral and pharmacological support in the academic setting. - C: Incorrect because while ADHD can co-occur with ASD, the immediate priority for active aggression, peer poking, and daily temper tantrums is managing ASD-related irritability with ABA therapy and FDA-approved pharmacotherapy. - D: Incorrect because strict punitive discipline is ineffective and inappropriate for managing neurodevelopmental deficits and irritability in **Autism Spectrum Disorder**. 💡 Next step in your review: Consider working through active recall questions on pediatric ADHD stimulant vs. non-stimulant management to reinforce developmental psychopharmacology. Next. New section. ADHD, ASD, and disruptive behavior: criteria, age gates, and first-line. Topic. Disruptive Behavior Disorders: ODD vs. Conduct Disorder. Bottom Line. - **Oppositional Defiant Disorder (ODD)** requires a persistent pattern of angry or irritable mood, argumentative or defiant behavior, or vindictiveness lasting at least 6 months, exhibited with at least one individual who is not a sibling. - Diagnostic age gates for **ODD** require symptoms on most days for at least 6 months in children under 5 years of age, and at least once per week for at least 6 months in individuals 5 years of age or older. - **Conduct Disorder (CD)** requires a repetitive pattern violating the basic rights of others or major societal rules, evidenced by at least 3 criteria in the past 12 months, with at least 1 criterion present in the past 6 months. - **Conduct Disorder** features four major symptom domains: aggression to people and animals, destruction of property, deceitfulness or theft, and serious violations of rules. - Age of onset divides **Conduct Disorder** into Childhood-Onset (at least 1 criterion present before age 10, carrying a worse prognosis) and Adolescent-Onset (no criteria before age 10). - An individual must be under 18 years of age for a diagnosis of **Conduct Disorder**. If the individual is 18 years or older, criteria for **Antisocial Personality Disorder** must be evaluated instead. - **First-line** treatment for **ODD** is family behavioral therapy and parent management training. **First-line** treatment for **Conduct Disorder** consists of multi-systemic therapy, social skills training, and family education. - Pharmacotherapy is not first-line for either condition. Medications are reserved for comorbid disorders such as **ADHD** or for managing severe, refractory aggression using agents like **risperidone**. - Poor academic performance is a common functional outcome of both disorders, but it is not a diagnostic criterion for either condition. High-Yield Concept Map. Oppositional Defiant Disorder (ODD). - **What it is:** A pediatric behavioral disorder defined by an enduring pattern of emotional dysregulation, verbal defiance, hostility, and spitefulness toward authority figures. - **Why boards care:** The exam tests your ability to distinguish verbal hostility and boundary-testing from the physical aggression, property damage, and illegal acts seen in **Conduct Disorder**. - **Must know criteria and features:** Symptoms must persist for at least 6 months and include at least 4 symptoms from three categories: Angry or Irritable Mood (loses temper, touchy, angry), Argumentative or Defiant Behavior (argues with authority figures, actively defies rules, deliberately annoys others, blames others for mistakes), or Vindictiveness (spiteful or vindictive at least twice in 6 months). - **Typical board clue:** A 7-year-old child who argues with teachers, loses his temper, blames classmates for his own mistakes, and deliberately annoys peers, but shows no physical cruelty or property destruction. - **First-line approach:** Family behavioral therapy and parent management training. - **When the answer changes:** If the child begins physically harming animals, setting fires, stealing, or running away overnight, the diagnosis escalates to **Conduct Disorder**. - **Safety alert:** Evaluate for comorbid **ADHD**, **major depressive disorder**, and **anxiety disorders**, which occur in up to 70% of affected youth. Conduct Disorder (CD). - **What it is:** A severe behavioral disorder characterized by a repetitive pattern of violating basic human rights and major age-appropriate societal rules or laws. - **Why boards care:** Tested heavily on safety priorities, age of onset specifiers, legal violations, and differential diagnosis with adult **Antisocial Personality Disorder**. - **Must know criteria and features:** Requires at least 3 of 15 criteria in the past 12 months, with at least 1 present in the past 6 months, across four core domains: Aggression to People and Animals (bullying, physical fights, weapon use, physical cruelty, forced sexual activity), Destruction of Property (arson, vandalism), Deceitfulness or Theft (breaking and entering, conning, shoplifting), and Serious Violations of Rules (truancy before age 13, running away overnight, staying out late before age 13). - **Typical board clue:** A 14-year-old adolescent boy with a history of physical fights, animal cruelty, fire-setting, shoplifting, and running away overnight. - **First-line approach:** Multi-systemic therapy, family behavioral therapy, and social skills training. Out-of-home residential placement may be required for severe safety violations. - **When the answer changes:** If the patient reaches 18 years of age and demonstrates a pattern of disregard for the rights of others since age 15, the diagnosis changes to **Antisocial Personality Disorder**. - **Safety alert:** Conduct Disorder carries high risks of physical violence, fire-setting, weapon use, cruelty to animals, and co-occurring substance use disorder. Immediate risk assessment for harm to others is essential. Compare and Distinguish. Oppositional Defiant Disorder vs. Conduct Disorder. - **Do not confuse:** **ODD** centers on verbal defiance, hostility, and emotional dysregulation without major property damage or physical aggression. **Conduct Disorder** centers on overt property destruction, physical harm, theft, and societal rule violations. - **Think ODD when:** The child loses temper, argues with adults, defies rules, blames others for mistakes, and deliberately annoys people, but does not commit illegal acts or physical harm. - **Think Conduct Disorder when:** The youth steals, sets fires, uses weapons, displays physical cruelty to animals or people, or stays out overnight before age 13. - **Priority difference:** **ODD** is managed in outpatient settings with family behavioral interventions. **Conduct Disorder** presents immediate safety and legal risks requiring comprehensive multi-systemic safety planning and potential residential care. - **What boards are really testing:** Recognizing the boundary between emotional/verbal defiance (**ODD**) and physical aggression/lawbreaking (**Conduct Disorder**), as well as understanding that academic failure is an associated outcome, not a diagnostic criterion. - **Classic distractor:** Choosing medication (like an **SSRI** or stimulant) as the primary treatment for **ODD** or **Conduct Disorder**, or selecting poor academic performance as a required diagnostic criterion. Key Exam Signposts and Board Pearls. - **First-line:** Psychotherapy and behavioral interventions are always first-line. Family behavioral therapy for **ODD**; multi-systemic therapy and social skills training for **Conduct Disorder**. - **Board trap:** Believing that poor academic performance or failing grades is a diagnostic criterion for **Conduct Disorder** or **ODD**. Academic failure is a common consequence of these behaviors, not a diagnostic criterion. - **Board trap:** Prescribing psychotropic medications as the primary treatment for **ODD** or **Conduct Disorder**. Medications are only indicated to treat comorbid conditions like **ADHD** or to manage severe, refractory physical aggression with atypical antipsychotics like **risperidone**. - **Safety alert:** **Conduct Disorder** behaviors such as arson, weapon use, physical cruelty to animals or humans, and running away overnight represent immediate safety hazards that require protective intervention. Board-Style Practice Question Bank. Question 1. Peter is a healthy 7-year-old second grader who lives with his 4-year-old sister and his parents. He is brought to the clinic by his parents, who are concerned about an 8-month history of behavioral issues. He has an explosive temper, argues with his parents, and blames others for his mistakes. The teacher reports that he often does not follow directions, and when corrected, he becomes defensive and argumentative. The teacher witnessed him repeatedly prod a pencil into a classmate's bag. When he was confronted about this, he denied doing it. You consider the most appropriate course of action is: A) Start therapy with an SSRI B) Initiate family behavioral therapy C) Suggest limiting refined carbohydrates from his diet D) Advise the family that children of this age often outgrow this type of behavior Pause. **Answer:** B **Key Clue:** An 8-month history of explosive temper, arguing with parents, defying teacher directions, blaming others, and deliberate annoyance without physical violence or property destruction points to Oppositional Defiant Disorder. **Best Answer:** B. Initiate family behavioral therapy **Why It Is Correct:** Peter's clinical presentation meets criteria for Oppositional Defiant Disorder (**ODD**). The evidence-based **first-line** treatment for **ODD** is non-pharmacological behavioral management, specifically family behavioral therapy and parent management training. **Why the Other Choices Are Wrong:** - **A:** **SSRIs** are not indicated as **first-line** treatment for **ODD** unless there is a clear comorbid internalizing disorder such as major depressive disorder or anxiety. - **C:** Dietary modifications such as limiting refined carbohydrates lack clinical evidence and are not standard of care for **ODD**. - **D:** **ODD** behaviors cause significant impairment across multiple settings and do not simply resolve with time without structured intervention. **Test-Taking Pearl:** Non-pharmacological behavioral interventions, such as family behavioral therapy, are always the **first-line** treatment choice for Oppositional Defiant Disorder. Question 2. Clinical features supporting the diagnosis of conduct disorder in a 14-year-old boy include all of the following except: A) Theft B) Aggression to animals C) Destruction of property D) Poor academic performance Pause. **Answer:** D **Key Clue:** The question asks for the item that is NOT a diagnostic criterion for Conduct Disorder. **Best Answer:** D. Poor academic performance **Why It Is Correct:** Diagnostic criteria for **Conduct Disorder** focus on behaviors that violate the basic rights of others or major societal rules across four categories: aggression to people and animals, destruction of property, deceitfulness or theft, and serious violations of rules. While poor academic performance frequently co-occurs as a functional impairment or consequence, it is not a diagnostic criterion for **Conduct Disorder**. **Why the Other Choices Are Wrong:** - **A:** Theft and deceitfulness form one of the four main diagnostic criterion categories for **Conduct Disorder**. - **B:** Aggression to people and animals, including physical cruelty, is a core diagnostic category for **Conduct Disorder**. - **C:** Destruction of property, such as deliberate fire-setting or vandalism, is a core diagnostic category for **Conduct Disorder**. **Test-Taking Pearl:** Always distinguish diagnostic criteria from associated features or functional outcomes on board exams. Academic impairment is an outcome, not a diagnostic criterion for Conduct Disorder. Next. End of this drive.